Dapcel, Inc. is a biotechnology company specializing in the optimization of recombinant protein production through innovative gene redesign strategies. Their unique Two-Layered DAPCEL™ RC (Rare Codon) Gene Optimization approach emphasizes the significance of rare codons and the kinetics of protein translation. This method aims to enhance protein expression and ensure that proteins are correctly folded and soluble, addressing common challenges faced in the production of recombinant proteins in various host organisms. By focusing on synonymous codon usage, Dapcel's technology seeks to improve the overall yield and quality of protein products, which is critical for research and therapeutic applications.

In addition to their protein optimization technology, Dapcel offers a range of products and services, including recombinant proteins, specialized cell lines, and custom protein production and purification services. Their recombinant proteins are noted for their superior quality in terms of structure, folding, and bioactivity, making them a valuable resource for researchers studying various biological processes. Dapcel's cell lines are designed for investigating molecular mechanisms related to normal and disease states, further supporting the research community in understanding complex biological phenomena. Overall, Dapcel's commitment to advancing protein production technologies positions them as a key player in the biotechnology sector.

United States

DAPCEL, Inc. is a research biotechnology company focused on the development of strategies for optimization of enhanced protein production in any desired host organism. To this end DAPCEL, Inc. utilizes unique Two-Layered DAPCEL™ RC (Rare Codon) Gene Optimization approach for gene redesign.

Dapcel

Company Details